Sichuan HongRi Pharma-Tech

Sichuan HongRi Pharma-Tech is a core subsidiary of Tianjin HongRi Pharmaceutical, located in Chengdu, China. The company serves as a specialized research, development, and manufacturing hub focusing on chemical drugs, active pharmaceutical ingredients (APIs), and the modernization of Traditional Chinese Medicine (TCM). It is instrumental in the production of the group's flagship products, most notably Xuebijing Injection, which is widely used in China for the treatment of sepsis and critical care conditions. Sichuan HongRi Pharma-Tech operates high-standard GMP facilities and is actively expanding its pipeline into innovative small molecule therapies for oncology and inflammatory diseases. The company integrates advanced pharmaceutical technology with traditional medical knowledge to provide high-quality healthcare solutions both domestically and for international markets.